This from the Pharma letter. India is the latest country to explore drug price controls to improve patient accessibility and a hard cap on drug profit margin, while promoting the use of generics.
In addition, there is also a provision in the proposal to pull a drug manufacturer's license if they are caught bribing physicians. Imagine! What's the world coming to?
Posted by Bruce Lehr August 11th 2010.